KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomarin Pharmaceutical (BMRN) Shares Outstanding (Diluted Average) (2017 - 2025)

Biomarin Pharmaceutical's Shares Outstanding (Diluted Average) history spans 12 years, with the latest figure at $197.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) changed 0.35% year-over-year to $197.4 million, compared with a TTM value of $197.4 million through Dec 2025, changed 0.35%, and an annual FY2025 reading of $197.4 million, changed 0.35% over the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $197.4 million at Biomarin Pharmaceutical, roughly flat from $196.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $200.1 million in Q2 2024, with the low at $182.9 million in Q4 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $192.7 million, with a median of $194.6 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Diluted Average) fell 7.32% in 2021 and then rose 5.71% in 2022.
  • Tracing BMRN's Shares Outstanding (Diluted Average) over 5 years: stood at $182.9 million in 2021, then rose by 3.34% to $189.0 million in 2022, then increased by 1.39% to $191.6 million in 2023, then increased by 2.67% to $196.7 million in 2024, then increased by 0.35% to $197.4 million in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Shares Outstanding (Diluted Average) are $197.4 million (Q4 2025), $196.9 million (Q3 2025), and $196.6 million (Q2 2025).